Cargando…
AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma
A large proportion of bladder cancer (BLCA) patients suffer from malignant progression to life-threatening muscle-invasive bladder cancer (MIBC). Inflammation is a critical event in cancer development, but little is known about the role of inflammation in BLCA. In this study, the expression of the i...
Autores principales: | Zhou, Houhong, Zhang, Lei, Luo, Weihan, Hong, Huaishan, Tang, Dongdong, Zhou, Dewang, Zhou, Lingli, Li, Yuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659910/ https://www.ncbi.nlm.nih.gov/pubmed/36386141 http://dx.doi.org/10.3389/fphar.2022.1050774 |
Ejemplares similares
-
Identification and Development of Inflammatory Response–Related Genes Signature Associated With Prognosis Evaluation and Immune Status of Bladder Cancer
por: Zheng, Haoxiang, et al.
Publicado: (2022) -
The m(6)A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
por: Zhang, Lei, et al.
Publicado: (2023) -
Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer
por: Buss, Julieti Huch, et al.
Publicado: (2018) -
Taohong siwu decoction attenuates AIM2 and NLRC4 inflammasomes by ameliorates deoxyribonucleic acid damage after ischemic stroke
por: Wang, Ni, et al.
Publicado: (2022) -
Ferroptosis: A new therapeutic target for bladder cancer
por: Zeng, Fan, et al.
Publicado: (2022)